NO20015288D0 - Anvendelse av makrolide forbindelser for behandling av tört öye - Google Patents

Anvendelse av makrolide forbindelser for behandling av tört öye

Info

Publication number
NO20015288D0
NO20015288D0 NO20015288A NO20015288A NO20015288D0 NO 20015288 D0 NO20015288 D0 NO 20015288D0 NO 20015288 A NO20015288 A NO 20015288A NO 20015288 A NO20015288 A NO 20015288A NO 20015288 D0 NO20015288 D0 NO 20015288D0
Authority
NO
Norway
Prior art keywords
treatment
dry eye
macrolide compounds
macrolide
compounds
Prior art date
Application number
NO20015288A
Other languages
English (en)
Norwegian (no)
Other versions
NO20015288L (no
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22452015&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20015288(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of NO20015288L publication Critical patent/NO20015288L/no
Publication of NO20015288D0 publication Critical patent/NO20015288D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
NO20015288A 1999-04-30 2001-10-29 Anvendelse av makrolide forbindelser for behandling av tört öye NO20015288D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13200999P 1999-04-30 1999-04-30
PCT/JP2000/002756 WO2000066122A1 (en) 1999-04-30 2000-04-26 Use of macrolide compounds for the treatment of dry eye

Publications (2)

Publication Number Publication Date
NO20015288L NO20015288L (no) 2001-10-29
NO20015288D0 true NO20015288D0 (no) 2001-10-29

Family

ID=22452015

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015288A NO20015288D0 (no) 1999-04-30 2001-10-29 Anvendelse av makrolide forbindelser for behandling av tört öye

Country Status (23)

Country Link
EP (1) EP1173177B2 (tr)
JP (2) JP5036934B2 (tr)
KR (1) KR20020015316A (tr)
CN (1) CN1190194C (tr)
AR (1) AR023807A1 (tr)
AT (1) ATE281167T1 (tr)
AU (1) AU777915B2 (tr)
BR (1) BR0011225A (tr)
CA (1) CA2372448A1 (tr)
CZ (1) CZ20013769A3 (tr)
DE (1) DE60015516T2 (tr)
ES (1) ES2232439T3 (tr)
HK (2) HK1043321B (tr)
HU (1) HUP0200864A3 (tr)
IL (1) IL146162A0 (tr)
MX (1) MXPA01010988A (tr)
NO (1) NO20015288D0 (tr)
NZ (1) NZ515339A (tr)
PT (1) PT1173177E (tr)
TR (1) TR200103119T2 (tr)
TW (1) TWI230066B (tr)
WO (1) WO2000066122A1 (tr)
ZA (1) ZA200108905B (tr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2232439T3 (es) * 1999-04-30 2005-06-01 Sucampo Ag Uso de compuestos macrolidos para el tratamiento de los ojos secos.
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
CN1259049C (zh) 2001-07-06 2006-06-14 苏坎波公司 包含白介素－2抑制剂和抗菌剂的局部给药组合物
PE20030828A1 (es) * 2002-03-04 2003-11-04 Novartis Ag Composicion oftalmica que comprende ascomicina
AU2003256068A1 (en) * 2002-08-09 2004-02-25 Sucampo Pharmaceuticals, Inc. Pharmaceutical compositions comprising fk506 derivatives and the ir use for the treatment of allergic diseases
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
WO2004062669A1 (en) * 2003-01-16 2004-07-29 Sucampo Ag Use of a macrolide compound for treating dry eye
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
US7083802B2 (en) 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
US7087237B2 (en) 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
CA2541302A1 (en) 2003-10-06 2005-04-14 Ophtecs Corporation Ophthalmic composition for treating tear dysfunction
AU2006213673A1 (en) 2005-02-09 2006-08-17 Santen Pharmaceutical Co., Ltd. Formulations for ocular treatment
AU2006270041B2 (en) 2005-07-18 2011-08-18 Minu, Llc Enhanced ocular neuroprotection/neurostimulation
CA2635797C (en) 2006-02-09 2015-03-31 Macusight, Inc. Stable formulations, and methods of their preparation and use
JP5506378B2 (ja) 2006-03-23 2014-05-28 参天製薬株式会社 血管透過性に関連する疾患または病気のための製剤および方法
EP2335735A1 (en) * 2009-12-14 2011-06-22 Novaliq GmbH Pharmaceutical composition for treatment of dry eye syndrome
WO2018220444A2 (en) * 2017-05-30 2018-12-06 Eximore Ltd. Compositions and methods for treating dry eye syndrome delivering antibiotic macrolide
US11766421B2 (en) 2017-09-25 2023-09-26 Surface Ophthalmics, Inc. Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA905202B (en) * 1989-07-05 1991-04-24 Fujisawa Pharmaceutical Co Aqueous liquid composition for external use
JP3158437B2 (ja) * 1991-04-26 2001-04-23 藤沢薬品工業株式会社 眼疾患に対するマクロライド化合物の使用
IL102414A (en) * 1991-07-25 1996-08-04 Univ Louisville Res Found Medicinal preparations for the treatment of ocular inflammation, containing rapamycin
AR004480A1 (es) * 1995-04-06 1998-12-16 Amico Derin C D Compuestos de ascomicina que poseen actividad antiinflamatoria, pro cedimiento para prepararlos, uso de dichos compuestos para preparar agentesfarmaceuticos y composiciones farmaceuticas que los incluyen
GB9601120D0 (en) * 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
US6673807B1 (en) * 1998-04-06 2004-01-06 Fujisawa Pharmaceutical Co., Ltd. Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins
IL139210A (en) * 1998-04-27 2005-11-20 Fujisawa Pharmaceutical Co Pharmaceutical composition containing a macrolide compound
US6376517B1 (en) * 1998-08-14 2002-04-23 Gpi Nil Holdings, Inc. Pipecolic acid derivatives for vision and memory disorders
ES2232439T3 (es) * 1999-04-30 2005-06-01 Sucampo Ag Uso de compuestos macrolidos para el tratamiento de los ojos secos.

Also Published As

Publication number Publication date
WO2000066122A1 (en) 2000-11-09
HK1043321A1 (en) 2002-09-13
PT1173177E (pt) 2005-03-31
IL146162A0 (en) 2002-07-25
MXPA01010988A (es) 2004-04-21
JP2012116857A (ja) 2012-06-21
CZ20013769A3 (cs) 2002-03-13
CN1353608A (zh) 2002-06-12
DE60015516D1 (de) 2004-12-09
ZA200108905B (en) 2002-12-24
EP1173177B2 (en) 2014-03-05
DE60015516T2 (de) 2005-12-01
TWI230066B (en) 2005-04-01
BR0011225A (pt) 2002-03-19
KR20020015316A (ko) 2002-02-27
EP1173177B1 (en) 2004-11-03
EP1173177A1 (en) 2002-01-23
TR200103119T2 (tr) 2002-04-22
AR023807A1 (es) 2002-09-04
AU4142900A (en) 2000-11-17
JP5036934B2 (ja) 2012-09-26
HUP0200864A2 (hu) 2002-07-29
NO20015288L (no) 2001-10-29
NZ515339A (en) 2004-02-27
CA2372448A1 (en) 2000-11-09
HUP0200864A3 (en) 2004-07-28
AU777915B2 (en) 2004-11-04
ATE281167T1 (de) 2004-11-15
HK1046099A1 (zh) 2002-12-27
CN1190194C (zh) 2005-02-23
JP2002543132A (ja) 2002-12-17
ES2232439T3 (es) 2005-06-01
HK1043321B (zh) 2005-07-15

Similar Documents

Publication Publication Date Title
NO20014379D0 (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
NO20021474L (no) Forbindelser for behandling av ischemi
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
NO20015288D0 (no) Anvendelse av makrolide forbindelser for behandling av tört öye
NO20013380L (no) 2-aminobenzoksazinonderivater for behandling av fedme
DE60028014D1 (de) Steuerbare endoskophülle
PT1210113E (pt) Composicoes de vacinas de combinacao
FI20000863A (fi) Uusi hoitomenetelmä
NO20022087D0 (no) Fremgangsmåte for behandling av diabetes
NO20013381D0 (no) 2-oksybenzoksazinonderivater for behandling av fedme
PT1235831E (pt) Novos compostos de oxabispidina uteis no tratamento de arritmias cardiacas
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20023482D0 (no) Fremgangsmåte for behandling av stoffmisbruk
NO20022245L (no) Onkolyttiske kombinasjoner for behandling av cancer
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
NO20024776L (no) Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte
NO20026219L (no) Forbindelser for behandling av svekket fundisk relaksasjon
NO20020784L (no) Medikament for behandling av brudd
NO20012541D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
NO20012540D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
NO20013385L (no) S-nitrosotioler som midler for behandling av sirkulatoriske dysfunksjoner
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
PT1140090E (pt) Utilizacao de fanquinona para o tratamento ou prevencao da perda de memoria

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application